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ABSTRACT
The mature sphingolipids of yeast consist of inositolphosphorylceramides (IPCs) and glycosylated 
derivatives thereof. Beyond being an abundant membrane constituent in the organelles of the 
secretory pathway, IPCs are also used to constitute the lipid moiety of the majority of GPI proteins, 
while a minority of GPI proteins contain Phosphatidylinositol (PI). Thus, all GPI anchor lipids (as 
well as free IPCs) typically contain C26 fatty acids. However, the primary GPI lipid that is added 
to newly synthesized proteins in the ER consists of a PI with conventional C16 and C18 fatty acids. 
A new class of enzymes is required to replace the fatty acid in sn-2 by a C26 fatty acid. Cells 
lacking this activity make normal amounts of GPI proteins but accumulate GPI anchors containing 
lyso-PI. As a consequence, the ER to Golgi transport of the GPI protein Gas1p is slow and mature 
Gas1p is lost from the plasma membrane into the medium. The GPI anchor containing C26 in sn-2
can further be remodeled by the exchange of diacylglycerol for ceramide. This process is also 
dependent on the presence of specific phosphorylethanolamine side chains on the GPI anchor. 
Abbreviations: CWP = cell wall protein; DAG = diacylglycerol; GlcN, GlcNH2 = D-glucosamine; 
GPI = glycosylphosphatidylinositol; IPC = inositolphosphorylceramide; Man = mannose; PI = 
phosphatidylinositol; PMP = plasma membrane protein. 
1. INTRODUCTION 
GPI anchoring is utilized by most eukaryotes to express proteins at the cell surface and 
Saccharomyces cerevisiae does not make an exception to this. Glycosylphosphatidylinositol (GPI) 
anchors are structurally complex glycophospholipids, which are added posttranslationally to the C-
terminal end of secretory proteins after they have been translocated into the ER. While a few yeast 
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GPI proteins reside permanently at the plasma membrane, a majority of them gets further 
processed and is integrated into the cell wall by a covalent attachment to cell wall glucans. Some of 
the estimated 60 GPI proteins predicted from the yeast genome sequence serve enzymatic 
functions required for the biosynthesis and the continuous shape adaptations of the cell wall, others 
seem to be structural elements of the cell wall, yet others mediate cell adhesion, and a few seem to 
have other functions [1-4]. The GPI biosynthetic pathway is absolutely necessary for growth and 
survival of yeast cells [5].
In all organisms, the precursors of GPI anchored proteins have a classical signal sequence for 
import into the ER at their N-terminus and a GPI anchoring signal at their C-terminus; the C-
terminal signal is necessary and sufficient to direct GPI addition [6]. The C-terminal GPI 
anchoring signal is recognized and removed by a GPI transamidase, which replaces it by the 
preformed GPI. GPI anchoring signals are composed of a C-terminal hydrophobic domain, which 
is separated by a short hydrophilic spacer from the cleavage/attachment site (Z-site) [7-9].
Fig. 1A shows the average structure of the yeast GPI anchor as elaborated from the total pool of 
GPI anchors extracted from yeast cells without the prior purification of any particular GPI protein 
[10, 11]. The structure of the GPI core linking the protein to the lipid moiety is highly conserved 
among all eukaryotes, as is true for the enzymes that elaborate the GPI structure. Amazingly, even 
certain side chains such as the forth mannose (Man4) or the phosphorylethanolamine side chains 
added on Man1 and Man2 (Fig. 1A) are present in both, man and yeast and thus may have been 
conserved across long evolutionary distances. Clearly, the GPI biosynthesis pathway is a very 
ancient and highly conserved pathway.
Twenty years after the complete structures for the variant surface glycoproteins of Trypanosoma
brucei and the mammalian Thy-1 glycoprotein had been worked out by the pioneering work of 
Mike Ferguson, Steve Homans and their coworkers in 1988 [12, 13], genes required for the 
addition of about everyone of the different structural elements of the GPI anchor have been 
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identified, but new subunits and regulatory elements of the identified enzymes still continue to be 
discovered. In yeast the GPI lipids are synthesized in the ER and added onto proteins by a pathway 
comprising 12 steps, carried out by 23 gene products, 19 of which are essential. Excellent recent 
reviews summarize current knowledge about the biosynthesis of GPI anchors and the enzymes that 
are necessary for their elaboration [14-19]. 
The present review focuses on our current understanding of the exchange of the lipid moiety of 
GPI anchors in yeast i.e. on GPI lipid remodeling, a phenomenon that is required to introduce 
ceramides into the GPI anchor and seems to be paradigmatic for a number of protozoa and fungi.  
2. BIOSYNTHESIS OF GPI LIPIDS IN YEAST 
The genes encoding the different enzymes involved in the biosynthesis of GPI anchors have been 
cloned mostly by the transfection of gene libraries into mammalian or yeast gpi mutants, which are 
deficient in GPI anchoring and therefore retain all GPI proteins in the ER so that they have no GPI 
proteins at their surface. By selecting for gpi transformants that reexpressed GPI proteins at their 
surface and thus contained a gene able to complement the mutant phenotype, a great number of 
genes have been identified, foremost by the group of Taroh Kinoshita in Japan and also by several 
other groups. The various steps are the same in yeast and in mammals and the genes involved in 
each step are summarized in Fig. 2. All genes indicated in Fig. 2 are essential except for GPI1,
ERI1, GPI7 and BST1. This list of genes may still be incomplete and one can speculate that there 
would also be a need for a flippase flipping PI-GlcN towards the ER lumen (Fig. 2). Moreover, 
flippases for other substrates such as acyl-CoA, dolichylphosphorylmannose and 
phosphatidylethanolamine may equally be involved. Although for all steps some subunit has been 
shown to be, or can safely be assumed to be the catalytic subunit, there remains a lot to be learned 
about the exact roles of additional subunits, which are required at steps 1, 4, 9, 10 and 11 of Fig. 2. 
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Another riddle to be solved concerns the role of the fatty acid that is added to the inositol of GPI 
lipids in many organisms, but which is usually taken off again just before or soon after the GPI 
lipid is added to proteins (steps 3 and 12, Fig. 2).
3. REMODELING OF GPI LIPID MOIETIES
3.1 General considerations 
Lipid remodeling is invoked in instances, in which the lipid moiety of the free GPI lipid or the GPI 
anchor attached to a protein is modified. One can infer a remodeling event if an early intermediate 
of the GPI lipid biosynthetic pathway, e.g. GlcN-acyl-PI, carries a different lipid moiety than later 
intermediates or protein-bound GPI anchors. Practically however, it often is not trivial to obtain 
sufficient material of the earliest GPI intermediates for analysis. In some cases there are significant 
amounts of GlcN-acyl-PI, but the bulk of this material may not be destined for GPI anchor 
biosynthesis, but rather serve to generate free GPI lipids. This seems to be the case for many 
mammalian cell lines that produce much more GPI lipids than what is needed for protein anchoring 
[20-23]. In these cases it needs to be demonstrated that an early intermediate really is in the 
pathway leading up to protein-anchoring GPI structures. In yeast, free GPI lipids are present in so 
low amounts that they are not easily detected and all information on GPI lipids derives from 
mutant cells having mutations in the GPI biosynthetic pathway. 
3.2 GPI remodeling in protozoa 
Trypanosoma brucei 
Historically, Trypanosoma brucei, the African sleeping sickness causing agent, was the first 
organism, in which GPI lipid remodeling was demonstrated. The GPI anchors of variable surface 
protein (VSG) of Trypanosoma brucei and Trypanosoma congolense are unique in having 
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exclusively myristate (C14:0) as fatty acid component of their diacylglycerol (DAG) moiety. 
While VSG is expressed by the blood forms present in the mammalian host, the procyclic froms of 
T. brucei express other GPI proteins, which contain different GPI anchor lipids. The myristates of 
VSG are introduced into GPI lipids by two independent and distinct pathways. First, the free GPI 
lipid undergoes "fatty acid remodeling" to replace both its fatty acids with myristate during the 
final phase of GPI biosynthesis [24]. Second, the myristoylated anchor undergoes a "myristate 
exchange" reaction, leading to the replacement of myristate by another myristate in both sn-1 and 
sn-2. This second reaction occurs mainly on the GPIs that already are linked to VSG. The fatty 
acid remodeling pathway and the myristate exchange are distinct as they have different enzymatic 
properties and probably occur in different subcellular compartments, but both pathways require 
myristoyl-CoA as a substrate [25]. The exchange reaction is proposed to be a proofreading system 
to ensure that the fatty acids on VSG are exclusively myristate [25, 26]. 
 The starting substrate for the first remodeling reactions in the bloodstream forms are complete GPI 
lipids containing C18:0 in sn-1 and C18:0, C18:1, C18:2, C20:4 or C22:6 in sn-2 [27]. The first 
reaction occurs at the sn-2 position of glycerol, and is followed by the subsequent attachment of 
myristate, donated from myristoyl-CoA. Then, the stearic acid at sn-1 is removed and the second 
myristate is incorporated. Monoacylated GPI (lyso-GPI) intermediates can be isolated in both cases 
[28]. An acyl-CoA binding protein (ACBP) showing a high affinity for myristoyl-CoA and 
enhancing fatty acid remodeling of GPI precursors in the trypanosome cell-free system has been 
cloned [29].
Trypanosoma cruzi 
Trypanosoma cruzi is the causative agent of Chagas' disease. Most of the surface proteins and 
glycoconjugates are attached to the membrane by a GPI anchor. The major free glycosylinositol 
phospholipids (GIPLs) and protein-linked GPIs in T. cruzi contain ceramide as lipid moiety. An 
alkylglycerol, either as a lyso species or acylated, has also been observed in GPI anchors whereas 
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DAG has never been detected. A recent study shows that the first step of the GPI biosynthesis does 
not use IPC as a substrate. This suggests that T. cruzi exchange a DAG for a ceramide generating a 
GPI anchor with a ceramide-based lipid, as it is the case in yeast [30]. 
Aspergillus fumigatus 
Aspergillus fumigatus is a filamentous fungus and human pathogen that expresses GPI-anchored 
proteins on its cell surface. Isolation of four GPI-anchored proteins and analysis of their anchor 
revealed that the lipid part consists exclusively of IPC, most likely containing C18-
phytosphingosine amide-linked to a monohydroxylated C24 saturated fatty acid. In contrast to 
yeast, no DAG was found in the GPI anchors of A. fumigatus [31]. A galactomannan 
polysaccharide of A. fumigatus has been shown to be GPI-anchored and to contain the same 
ceramide as the one present in GPI-anchored proteins [32]. A. fumigatus, as many other fungi, also 
contains glycosylinositol phosphorylceramides, which consist of a similar, ceramide-based GPI-
like structure [33]. As in other organisms, a cell free assay system shows that A. fumigatus initiates
GPI biosynthesis by the addition of GlcNAc to PI to give GlcNAc-PI (step 1, Fig. 2)[34]. This 
suggests that a lipid exchange must occur to replace the base-sensitive diacyl lipid moiety of the 
early GPI intermediate by a ceramide. 
Leishmania mexicana 
Leishmania mexicana are parasites alternating between a flagellated promastigote stage that 
proliferates in the midgut of the sand fly vector, and a non-motile amastigote stage that populates 
that phagolysosome of mammalian macrophages . Leishmania mexicana promastigotes are coated 
with a number of GPI-anchored proteins, and lipophosphoglycans (LPGs) and glycosylinositol 
phospholipids (so-called GIPLs). These three classes of molecules share a common GPI-like 
ManD1-4GlcND1-6inositol-phospholipid structure while their further carbohydrate structures are 
different.
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The early GPI anchor precursors of Leishmania mexicana fall into two distinct classes containing 
1-alkyl-2-acyl-glycerols with either a C18 alkyl chain, or very long alkyl chains (C24, C26). In the 
protein-linked GPIs, only C24/C26 alkyl GPIs are incorporated whereas GIPLs only contain C18 
alkyls. In the total cellular pool of glycerylphosphorylinositol lipids the C18 alkyl species accounts 
for 20%, the C24/C26 alkyl species for less than 1% [35]. The exclusive use of a rare 
glycerylphosphorylinositol lipid for GPI anchoring however is not thought of as being due to a 
remodeling reaction but rather to predilection for C24/C26 alkyls amongst the enzymes making 
GPIs for protein anchoring [19, 35].
However, Leishmania mexicana remodels the fatty acids of its free GIPLs by operating the 
removal of a C18 fatty acid from the the sn-2 position and incorporation of myristate in its stead, 
myristoly-CoA being the donor substrate. This reaction is reminiscent of the GPI lipid remodeling 
in T. brucei and may also occur on the GPIs used to anchor proteins [35]. 
3.3 GPI remodeling in mammalian organisms 
A number of human and mammalian GPI anchors contain 1-alkyl-2-acyl-glycerol or 1-alkyl- 
glycerol as lipid moieties, while other mammalian GPI proteins contain regular DAG anchors [16]. 
1-alkyl-2-acyl-sn-glycero-3-phosphorylinositol is present as free lipid in certain cell lines [36] and 
the alkyl-acyl-glycerol moieties are present already in the early steps of GPI biosynthesis in the 
same proportions as they are found in the mature GPI proteins [37-39], even when the level of 1-
alkyl-2-acyl-sn-glycero-3-phosphorylinositolphosphorylinositol in the cell is very low. This 
suggests (but does not prove) that the GPI-GlcNAc transferase achieving step 1 (Fig. 2) has a 
preference for 1-alkyl-2-acyl-sn-glycero-3-phosphorylinositol. Thus, as in L. mexicana, there is no 
need to invoke lipid remodeling to explain the presence of the very uncommon 1-alkyl-2-acyl-sn-
glycero-3-phosphorylinositols in mammalian GPI anchors. 
Interestingly, a recent report shows that mammalian GPI anchors seem to be remodeled and 
undergo a deacylation - reacylation cycle in the Golgi, mediated by PGAP2, which is believed to 
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act as an acyltransferase [40]. This suggests that GPI lipid remodeling of protein-bound anchors 
may be a common event also in mammalian cells but the benefit of this is presently unclear.
3.4 GPI remodeling in Saccharomyces cerevisiae 
The lipid moieties of mature GPI-anchors of Saccharomyces cerevisiae usually do not contain the 
DAG present on the GPI lipid at the stage when it is transferred by the transamidase to GPI 
proteins and which probably contains the C16 and C18 fatty acids found in yeast PI (Fig. 1)[41-
44]. Most mature GPI proteins of yeast contain a ceramide moiety, whereas a minor fraction 
contains a modified DAG containing C26:0 in sn-2 [10, 42](Fig. 1B). It has to be noted that 
ceramides of S.cerevisiae almost exclusively contain C26 fatty acids. Thus, all mature GPI proteins 
of yeast contain large lipid moieties with C26 or hydroxylated C26 fatty acids, either in the form of 
a ceramide or a special DAG and these lipids are introduced by remodeling enzymes that replace 
the primary lipid moiety of the anchor (Fig. 3A). Ceramides are also found in the GPI anchors in 
certain plants, (e.g. pears), Trypanosoma cruzi, Paramecium primaurelia, Aspergillus niger, 
Aspergillus fumigatus and Dictyostelium [16], sometimes as the sole anchor lipid [31].
The yeast remodeling activity introducing ceramide (ceramide remodelase) can be monitored by 
metabolic labeling experiments using tritiated DHS ([3H]DHS) [43]. When given to cells, this 
tracer is rapidly taken up and is incorporated into all sphingolipids as well as ceramide-containing 
GPI proteins. By metabolic labeling experiments in different secretion mutants with one finds that 
ceramide remodelase activity is present in both, the ER and beyond, i.e. the Golgi or the plasma 
membrane [43]. Ceramides with hydroxylated fatty acids (C26-OH) are only introduced in the 
Golgi while other remodeling reactions can occur in the ER. Even on mature proteins, the ceramide 
moieties continue to be turned over (Fig. 3A)[43]. The identity of the enzymes introducing 
ceramide is presently not known, but it is clear that this activity is different from Aur1p, the IPC 
synthase, which may perform a formally similar reaction. Indeed, the inhibition of Aur1p by 
aureobasidin A completely blocks IPC biosynthesis, but does not affect GPI remodeling, showing 
ht
tp
://
do
c.
re
ro
.c
h
  10 
that Aur1p does not mediate remodeling [45]. Moreover, short chain ceramides are ultilized by 
Aur1p but not by the ceramide remodelase. Many yeast strains, which have deletions in genes 
showing some homology with phospholipases A, B or C, with enzymes synthesizing or utilizing 
ceramides, with acyltransferases, or with other proteins binding acyl-CoA were tested for 
deficiences in GPI remodeling. Part of this effort has been published on the web by the 
EUROFAN2 lipid node at http://mips.gsf.de/proj/eurofan/eurofan_2/n7/conzelmann.html. 
Although some strains showed abnormalities in their sphingolipid profile, none of them was 
deficient in GPI remodeling. Incidentally it was found that gpi7' cells are deficient in Golgi 
remodeling [46]. It may be that the Golgi remodelase introducing ceramide needs GPI protein 
substrates carrying a phosphorylethanolamine on Man2 of their anchor. Renewed screening of 
deletion strains has recently identified GUP1 as being essential for the synthesis of the C26:0-
containing diacylglycerol anchors (Fig. 3B)(Bosson et al., in press). Gup1p is an ER membrane 
protein with multiple membrane spanning domains harboring a motif that is characteristic of 
membrane bound O-acyl-transferases (MBOAT motif). Present evidence suggests that Gup1p may 
act as an sn-2 specific acyltransferase in the remodeling of GPI anchors. 
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FIGURE LEGENDS 
Figure 1. Structure of GPI anchors of yeast. A, the average structure of the yeast GPI anchor as 
elaborated from the total pool of GPI anchors [10, 11]. The carbohydrate core structure, which is 
conserved throughout the eukaryotic kingdom is shown in bold characters. The box contains CP2, 
the most mature yeast GPI lipid accumulating in GPI transamidase mutants; CP2 contains 4 
mannoses (Man1 to Man 4) and phosphorylethanolamine (EtNH2-P) substituents on Man1, Man2 
and Man3. A 5th mannose (Man5) can be added to GPI proteins while they transit through the 
Golgi apparatus, whereby Man5 is added either in D1-2 or in D1-3 linkage [10, 47]. Although 
present on CP2, it is not certain that the EtNH2-P on Man2 is present on GPI anchors of proteins 
[11]. The palmitic acid on the inositol (Ins) is present on all but the earliest free GPI lipids but it is 
removed as soon as the GPI lipid is attached to a protein (see step 12 in Fig. 2). B, the two 
alternative lipid moieties found on mature GPI proteins are shown. In both lipid moieties, part of 
the C26 fatty acids are D-hydroxylated [10]. In CP2, x and y are probably 14 and 15, on mature 
protein anchors they are 14 and 23, respectively. 
Figure 2. The main pathway of GPI biosynthesis in yeast. Since no GPI intermediates are 
detectable in wild type cells, a likely order of 12 consecutive reactions is proposed based on 
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structures of GPIs accumulating in well characterized gpi mutants [46, 48-51]. CP2 is the most 
polar lipid accumulating in gpi8 mutants, M4 accumulates in gpi7¨ cells and is also transferred to 
GPI proteins [46].
Figure 3. Proposed remodeling reactions. A, the various lipids found on mature GPI anchored 
proteins are depicted together with the presumed base-sensitive PI (top) that is present on CP2 
(Fig. 1) and is transferred to proteins by the transamidase. A kinetic analysis of anchor lipids 
appearing after various times of metabolic labeling of cells with [3H]inositol suggests that the 
anchors with a C16/C18 DAG are first transformed into anchors with C16/C26 fatty acids and only 
thereafter ainto ceramide (Cer) containing anchors as indicated by the arrows 1 and 2 on the left 
[42]. Recent data confirm this notion (Bosson et al., in press). The arrows to the right are to show 
that ceramides continue to be exchaged for ceramides even on mature GPI proteins [43]. B, recent 
data indicate that arrow 1 in panel A consists of 2 reactions, one of which depends on GUP1. Other 
data however suggest that a direct transition from anchors with a C16/C18 containing DAG to a 
ceramide anchor may also take place (thin arrows; panel A, arrow 3)(Bosson et al., in press).  
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